Retrospective analysis shows equivalent outcomes for primary cutaneous anaplastic large cell lymphoma in academic and community cancer programs, suggesting comparable care.
Key Points
This study aims to analyze demographics, treatment patterns, and outcomes of primary cutaneous anaplastic large cell lymphoma (PC-ALCL) across different U.S. cancer care settings.
Conducted a retrospective analysis of PC-ALCL cases reported to the National Cancer Database between 2004 and 2022.
Compared demographic, clinical, and survival data between patients treated at academic cancer programs (ACPs) and community cancer programs (CCPs).
Utilized Kaplan-Meier and Cox proportional hazards models to compare overall survival (OS) based on various factors.
2,618 PC-ALCL patients identified, with similar male to female ratios across ACPs and CCPs.
CCP-treated patients were older, median age 69 vs. 65 years for ACPs.
No statistically significant survival advantage for treatment at ACPs compared to CCPs, suggesting equivalent care.